MARA Holdings
MARA
MicroStrategy
MSTR
Coinbase
COIN
Tesla
TSLA
Amazon
AMZN
US Stock MarketDetailed Quotes
CARA Cara Therapeutics
- 4.650
- +0.050+1.09%
Close Jan 17 16:00 ET
- 4.650
- 0.0000.00%
Post 16:00 ET
21.26MMarket Cap-0.22P/E (TTM)
4.790High4.510Low11.27KVolume4.680Open4.600Pre Close52.16KTurnover0.29%Turnover RatioLossP/E (Static)4.57MShares13.80052wk High29.81P/B18.13MFloat Cap2.70852wk Low--Dividend TTM3.90MShs Float355.768Historical High--Div YieldTTM6.08%Amplitude2.700Historical Low4.630Avg Price1Lot Size
About Cara Therapeutics Company
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.
Company Profile
SymbolCARA
Company NameCara Therapeutics
Listing DateJan 31, 2014
Issue Price11.00
Founded2004
CEOMr. Christopher A. Posner
MarketNASDAQ
Employees55
Fiscal Year Ends12-31
Address400 Atlantic Street,Suite 500
CityStamford
ProvinceConnecticut
CountryUnited States of America
Zip Code06901
Phone1-203-406-3700
Company Executives
- Name
- Position
- Salary
- Christopher A. Posner
- President, Chief Executive Officer and Director
- 2.92M
- Scott M. Terrillion
- General Counsel, Secretary and Chief Compliance Officer
- --
- Ryan D. Maynard
- Chief Financial Officer and Principal Accounting Officer
- 1.24M
- Martin A. Vogelbaum
- Chairman of the Board
- 519.99K
- Dr. Jeffrey L. Ives, PhD
- Independent Director
- 272.49K
- Helen M. Boudreau, M.B.A.
- Independent Director
- 376.01K
- Dr. Susan Shiff, M.B.A.,PhD
- Independent Director
- 262.49K
- Dr. Lisa von Moltke, M.D.
- Independent Director
- 254.99K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.